Here come the PD-1 agonists

If blocking PD-1 on T cells can release a brake on the immune system and revolutionise cancer treatment, the reverse could damp down immune response and have use in autoimmune diseases. This idea has been around for some time, and phase 2 data with Lilly’s peresolimab have provided evidence that the strategy could work in rheumatoid arthritis.